Delivery Order SPE2DB20D3103-SPE2DB25FQ3E3
- Not listed
- The Defense Logistics Agency awarded a $2,497.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with completion targeted for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate, an antiviral medication. The contract has a firm fixed price of $3,632.62 and a completion date of December 9, 2022. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units, with a ceiling value of $4,916.56. The contract is a firm fixed price delivery order with an ultimate completion date of June 30, 2025, and was awarded on a competitive, non-set-aside basis. The vendor will perform this work from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,706.51 firm fixed-price delivery order is for the purchase of 4,565,313,607 units of Oseltamivir 75mg, a medication used to treat and prevent influenza. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,449,252 units of the pharmaceutical drug Oseltamivir Phosphate 75 mg capsules. The $1,022.92 order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a range of pharmaceutical products and medical supplies to the Department of...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...
- This federal contract award, valued at $1,272.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,646,936 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of October 31, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The $1,318.40 firm fixed price contract does not have a set-aside designation and has an ultimate completion date of July 25, 2024. AmerisourceBergen is delivering the medication under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3E3Delivery Order
The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements, including antivirals such as Oseltamivir, across multiple therapeutic domains. The parent IDC enables AmerisourceBergen to supply medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key provider within the DLA's pharmaceutical procurement network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/16/25 |